State of Wyoming’s Vera Therapeutics VERA Stock Holding History

State of Wyoming’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28	Closed	–	–	1957
2022 Q2	$0	Buy	+28	New	+$489	﹤0.01%	2150

Other funds holding VERA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

State of Wyoming's VERA Position: Q3 2022 in Review

State of Wyoming sold out of Vera Therapeutics (VERA) in Q3 2022, closing a stake of 28 shares.

State of Wyoming first reported a position in VERA in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 55 funds tracked by Wall St. Rank hold VERA as of Q3 2022.

State of Wyoming reported no remaining Vera Therapeutics position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 28 Vera Therapeutics shares in Q3 2022.
State of Wyoming first reported a position in Vera Therapeutics in Q2 2022 and held it in 1 quarter.
State of Wyoming's Vera Therapeutics position peaked at $0 in Q2 2022.
55 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.